MDBio Ventures
Overview
As the investment arm of MD Biosciences, MDBio Ventures specializes in seed and Series A investments in companies developing pharmaceutical, diagnostic, and medical device technologies. With over 30 years of experience in early-stage drug and device development, the firm is dedicated to advancing the next generation of healthcare solutions. MDBio Ventures emphasizes a hands-on approach, providing not only capital but also scientific guidance and support to its portfolio companies. The firm is particularly interested in areas such as neurodegenerative diseases, wound healing, oncology, AI-driven drug discovery, surgical tools, and diagnostics. The firm's investment strategy includes a $50 million in-kind investment fund, MDBV-1, which aims to support a portfolio of 30 companies with commitments ranging from $250,000 to $2.5 million. This fund is designed to de-risk early-stage technologies and accelerate their path to market, reflecting MDBio Ventures' commitment to shaping the future of healthcare and benefiting humanity.
Investment Focus
- Companies developing pharmaceutical, diagnostic, and medical device technologies at seed or Series A stages.
Reach MDBio Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about MDBio Ventures
What sectors does MDBio Ventures invest in?
MDBio Ventures invests in Pharmaceuticals, Medical Devices and Diagnostics, and is based in United States. MDBio Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does MDBio Ventures invest at?
MDBio Ventures backs companies at Seed and Series A, writing cheques of 250K - 2.5M.
Which regions does MDBio Ventures invest in?
MDBio Ventures invests across United States.
Last updated · Source: ConnectSafely investor database
